European Urology Focus The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50–69 yr Compared with Current Prostate Cancer Testing Martin Eklund, Tobias Nordström, Markus Aly, Jan Adolfsson, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Joseph C. Presti, Mark StLezin, Mark Clements, Lars Egevad, Henrik Grönberg European Urology Focus DOI: 10.1016/j.euf.2016.10.009 Copyright © 2016 Terms and Conditions
Fig. 1 Comparison of Gleason Score ≥7 detection rate and biopsy results in different prostate-specific antigen (PSA) ranges for Current Prostate Cancer Testing (CPT) and Stockholm-3 Model (S3M), respectively. CI=confidence interval; GS=Gleason Score. European Urology Focus DOI: (10.1016/j.euf.2016.10.009) Copyright © 2016 Terms and Conditions